SouthState Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.6K | Sell |
45
-7
| -13% | -$3.68K | ﹤0.01% | 618 |
|
|
2025
Q1 | $33K | Buy |
52
+44
| +550% | +$27.9K | ﹤0.01% | 598 |
|
|
2024
Q4 | $5.7K | Buy |
8
+3
| +60% | +$2.14K | ﹤0.01% | 557 |
|
|
2024
Q3 | $5.26K | Hold |
5
| – | – | ﹤0.01% | 519 |
|
|
2024
Q2 | $5.26K | Buy |
5
+4
| +400% | +$4.2K | ﹤0.01% | 532 |
|
|
2024
Q1 | $962 | Buy |
+1
| New | +$962 | ﹤0.01% | 649 |
|
|
2023
Q2 | – | Sell |
-8
| Closed | -$6.57K | – | 637 |
|
|
2023
Q1 | $6.57K | Sell |
8
-25
| -76% | -$20.5K | ﹤0.01% | 551 |
|
|
2022
Q4 | $23.8K | Hold |
33
| – | – | ﹤0.01% | 450 |
|
|
2022
Q3 | $23K | Buy |
33
+8
| +32% | +$5.58K | ﹤0.01% | 451 |
|
|
2022
Q2 | $15K | Hold |
25
| – | – | ﹤0.01% | 533 |
|
|
2022
Q1 | $17K | Hold |
25
| – | – | ﹤0.01% | 549 |
|
|
2021
Q4 | $16K | Hold |
25
| – | – | ﹤0.01% | 513 |
|
|
2021
Q3 | $15K | Buy |
+25
| New | +$15K | ﹤0.01% | 458 |
|